Pet Obesity Management Market Summary
As per Market Research Future Reports analysis, the Pet Obesity Management Market size was valued at USD1.002 Billion in 2024. The market is projected to grow from USD1.08 Billion in 2025 to USD2.29 Billion by 2035, exhibiting a CAGR of 7% during the forecast period 2025–2035. North America led the market with over 49.9% share, generating around USD 0.5 billion in revenue.
Rising global prevalence of Alzheimer’s disease and increasing emphasis on early diagnosis are major growth drivers, encouraging adoption of advanced diagnostic technologies, improving patient outcomes, and supporting healthcare systems in managing the growing burden of neurodegenerative disorders effectively.
According to WHO, over 55 million people live with dementia globally, with nearly 10 million new cases annually, highlighting strong demand for early diagnostic solutions.
Key Market Trends & Highlights
The Pet Obesity Management Market is experiencing a dynamic shift towards innovative solutions and heightened awareness among pet owners.
- North America dominates with over 49.9% share in 2024, driven by advanced healthcare infrastructure and early diagnostic adoption.
- Europe holds nearly 30% market share, valued at USD 0.3 billion in 2024, supported by strong research and healthcare systems.
- Market projected to grow from USD 1.002 billion in 2024 to USD 2.29 billion by 2035, at 7% CAGR.
- Increasing adoption of AI-based diagnostics and biomarker technologies is improving early detection accuracy, supporting better disease management outcomes globally.
Market Size & Forecast
| 2024 Market Size | 1.002 (USD Billion) |
| 2035 Market Size | 2.29 (USD Billion) |
| CAGR (2025 - 2035) | 7.8% |
Major Players
Companies such as Nestle Purina Petcare (US), Mars Petcare (US), Hill's Pet Nutrition (US), Spectrum Brands (US), PetSmart (US), Royal Canin (FR), Blue Buffalo (US), WellPet (US), Boehringer Ingelheim (DE) are some of the major participants in the global market.